Cargando…

Epigenetic checkpoint blockade: new booster for immunotherapy

Detalles Bibliográficos
Autores principales:	Wang, Ziqiao, Wang, Bingjing, Cao, Xuetao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298415/ https://www.ncbi.nlm.nih.gov/pubmed/34294683 http://dx.doi.org/10.1038/s41392-021-00707-z

Ejemplares similares

Transcriptional suppression of CD8(+) T cell exhaustion for improving T cell immunotherapy
por: Yang, Xue, et al.
Publicado: (2021)

Reversing epigenetic repression of transposable elements for improving tumor immunogenicity
por: Wang, Xi, et al.
Publicado: (2022)

Deletion of the RNA-editing enzyme ADAR1A: new strategy to potentiate responses to PD-1 immune checkpoint blockade
por: Wang, Manni, et al.
Publicado: (2019)

Mitochondrial pyruvate carrier: a metabolic-epigenetic checkpoint orchestrating T cell differentiation
por: Chen, Yu, et al.
Publicado: (2022)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Highlight—Epigenetics Virtual Issue: New Findings Amid Old Controversies
por: McGrath, Casey
Publicado: (2022)

B-cell immune checkpoint TIM-1: a potential target for tumour immunotherapy
por: Tian, Xinyu, et al.
Publicado: (2023)

On the road to epigenetic therapy
por: Walton, Emma L.
Publicado: (2016)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

Clonal replacement of novel T cells: a new phenomenon in the tumor microenvironment following PD-1 blockade
por: Li, Xue, et al.
Publicado: (2019)

A new timepiece: an epigenetic mitotic clock
por: Christensen, Brock C., et al.
Publicado: (2016)

Highlight: Epigenetics Help Hydra Get Ahead
por: McGrath, Casey
Publicado: (2021)

Highlight: The Epigenetics of Life at 12,000 ft
por: McGrath, Casey
Publicado: (2021)

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020)

New strategy for cancer immunotherapy: using live engineered bacteria for metabolic modulation
por: Li, Tong, et al.
Publicado: (2021)

High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
por: Tang, Fei, et al.
Publicado: (2018)

Fumarate hydratase: a new checkpoint of metabolic regulation in inflammatory macrophages
por: Jeridi, Aicha, et al.
Publicado: (2023)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Identification of immune‐activating metabolite for enhancing T cell therapy of cancer
por: Cong, Boyi, et al.
Publicado: (2021)

Genome-wide in vivo screen identifies host molecule in promoting cancer metastasis
por: Gu, Yan, et al.
Publicado: (2017)

A role for complement blockade in kidney transplantation
por: Karpman, Diana, et al.
Publicado: (2022)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Normalization cancer immunotherapy: blocking Siglec-15!
por: Cao, Guangchao, et al.
Publicado: (2019)

Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
por: Wang, Feihu, et al.
Publicado: (2020)

Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling
por: Zhang, Liyi
Publicado: (2019)

CD5: from antiquated T cell marker to immunotherapy’s new hope
por: Schwarz, Sandra, et al.
Publicado: (2023)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Environment, epigenetics and reproduction
por: Skinner, Michael K
Publicado: (2017)

Constant regulation for stable CD8 T‐cell functional avidity and its possible implications for cancer immunotherapy
por: Gilfillan, Connie B., et al.
Publicado: (2021)

Epitherapy and immune checkpoint blockade: using epigenetic reinvigoration of exhausted and dysfunctional T cells to reimburse immunotherapy response
por: McGoverne, Isabella, et al.
Publicado: (2020)

Cytotoxic FCER1G(+) innate-like T cells: new potential for tumour immunotherapy
por: Morrish, Emma, et al.
Publicado: (2022)

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
por: Marcotte, Harold, et al.
Publicado: (2022)

Epigenetics in disease and well-being
por: Heriberto, Rodriguez-Martinez
Publicado: (2016)

2019 environment, epigenetics and reproduction
por: Skinner, Michael K
Publicado: (2019)

Fecal microbiota transplantation: can it circumvent resistance to PD-1 blockade in melanoma?
por: Derosa, Lisa, et al.
Publicado: (2021)

Epigenetics modulates the complexity of the response to Immune Checkpoint Blockade
por: Barragan, Isabel
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h52m8v7quc4ql9f32bi1umfodp